Biotechnology and drug discovery platform company
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Based on 1 scored insight about OmniAb, Inc..
The 1 sources with the most insights about OmniAb, Inc. on Kazuha.
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Strong bullish stance driven by royalty upside on a Johnson & Johnson drug candidate that could potentially become one of the biggest drugs globally.
Strong bullish stance driven by royalty upside on a Johnson & Johnson drug candidate that could potentially become one of the biggest drugs globally.
Other assets that creators frequently mention in the same content as OmniAb, Inc..
The most active sources covering OmniAb, Inc. (OABI) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
Kazuha has indexed 1 AI-extracted insight about OmniAb, Inc. (OABI) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
Creators covering OmniAb, Inc. (OABI) most frequently also discuss AMD, AMLX, CBRS, ORCL, NVDA. See the "Discussed alongside" section above for full asset pages.